The U.S. Food and Drug Administration (FDA) sent warnings to three beef producers, one pork producer, a seafood processor and a biscuit manufacturer in its latest round of warning letters. FDA wrote to Oak Hill Farm of Seward, PA, about selling a bob veal calf in July 2014 with tissue samples later revealed to contain neomycin, a drug that has no acceptable tolerance level. The farm was also told it used the drug in a way that did not conform to the label directions. Schneider Dairy of Westphalia, MI, was found to have sold a dairy cow for slaughter in February 2014 that contained more than 10 times the tolerance level for for desfuroylceftiofur, marker residue for the drug ceftiofur. FDA also found that the dairy failed to maintain complete drug treatment records and lacked clear directions from its veterinary clinic on using the drug. In Muleshoe, TX, another dairy, Stonegate Farms, sold a cow for slaughter in July 2014 that was found to have 13 times the tolerable level of penicillin in its kidneys and nearly 100 times the tolerable level of sulfadimethoxine in its liver. That dairy also failed to maintain complete treatment records of its cattle, according to FDA. Finally, Poeppelman Pork of Yorkshire, OH, was also found to have sold an animal for slaughter with excessive levels of drugs in its tissues. In February 2014, the pork producer allegedly sold a pig for slaughter that was found to have penicillin in its kidneys. FDA’s letter noted there is no tolerance level of penicillin in swine. Poeppelman Pork was also cited for failing to maintain complete treatment records, FDA stated. They were also found to have misused the new animal drug Agri-Cillin and did so without the supervision of a licensed veterinarian, the agency stated. Yamahide Shokuhin, a seafood processor and exporter in Miki-shi, Japan, did not have inadequate Hazard Analysis and Critical Control Points (HACCP) plans, according to FDA. The company was also found to have “significant deviations” from requirements, including a number of incomplete food safety plans for its dried shaved bonito product. In a warning letter sent to NP Foods Ltd., headquartered in Riga, Latvia, FDA stated the company had several wafer and biscuit products that were mislabeled, all related to incomplete nutritional information. The company also failed to include the common or usual name of the foods on the labels in English. In each letter, FDA requested that the companies provide written responses detailing steps taken to bring the facilities into compliance with food-safety laws and regulations, to correct violations cited in the letters, and to prevent their recurrence. Recipients of these warning letters have 15 working days from receipt to outline specific steps they have taken to come into compliance with the law.